Radiopharmaceutical tracer is developed to assist the diagnosis of Alzheimer’s disease
Life Molecular Imaging, a division of Alliance Medical Group, develops novel PET tracers for molecular imaging. The company’s first commercial product is NeuraCeq, a radiopharmaceutical tracer for PET imaging of patients that are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. The technology makes it possible to rule out AD or […]
Read More